AuroMedics Pharma, a U.S.-based unit of Indian drugmaker Aurobindo, issued a voluntary recall of one lot of the antibiotic polymyxin B following a complaint that a hair was found in a vial.

500,000 Unit per vial to the consumer level due to the presence of particulate matter, which was identified as hair discovered in a vial. The recalled lot of Polymyxin B for Injection USP ...

U.S. government health officials are alerting doctors to the recall of an injectable drug after vials of it were found to contain bits of metal, cotton, and hair. B. Braun Medical Inc. issued the ...